Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy vs triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK.

Kiff C, Ruiz S, Varol N, Gibson D, Davies A, Purkayastha D.

Int J Chron Obstruct Pulmon Dis. 2018 Sep 3;13:2707-2720. doi: 10.2147/COPD.S167730. eCollection 2018.

2.
3.

Alternative definitions of chronic bronchitis and their correlation with CT parameters.

Lim JU, Lee JH, Kim TH, Lee JS, Lee SD, Oh YM, Rhee CK.

Int J Chron Obstruct Pulmon Dis. 2018 Jun 13;13:1893-1899. doi: 10.2147/COPD.S164055. eCollection 2018.

4.

Distribution and characteristics of COPD phenotypes - results from the Polish sub-cohort of the POPE study.

Kania A, Krenke R, Kuziemski K, Czajkowska-Malinowska M, Celejewska-Wójcik N, Kuźnar-Kamińska B, Farnik M, Bokiej J, Miszczuk M, Damps-Konstańska I, Grabicki M, Trzaska-Sobczak M, Sładek K, Batura-Gabryel H, Barczyk A.

Int J Chron Obstruct Pulmon Dis. 2018 May 17;13:1613-1621. doi: 10.2147/COPD.S154716. eCollection 2018.

5.

Increased risk of respiratory diseases in adults with Type 1 and Type 2 diabetes.

George C, Ducatman AM, Conway BN.

Diabetes Res Clin Pract. 2018 Aug;142:46-55. doi: 10.1016/j.diabres.2018.05.029. Epub 2018 May 24.

PMID:
29802957
6.

Mortality in COPD patients according to clinical phenotypes.

Golpe R, Suárez-Valor M, Martín-Robles I, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Pérez de Llano LA.

Int J Chron Obstruct Pulmon Dis. 2018 May 1;13:1433-1439. doi: 10.2147/COPD.S159834. eCollection 2018.

7.

Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".

Alcázar-Navarrete B, Trigueros JA, Riesco JA, Campuzano A, Pérez J.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 10;13:1115-1124. doi: 10.2147/COPD.S158031. eCollection 2018.

8.

Prevalence and risk factors of asthma in mainland China: The CARE study.

Lin J, Wang W, Chen P, Zhou X, Wan H, Yin K, Ma L, Wu C, Li J, Liu C, Su N, Liu G, Xie H, Tang W, Huang M, Chen Y, Liu Y, Song L, Chen X, Zhang Y, Li W, Sun L.

Respir Med. 2018 Apr;137:48-54. doi: 10.1016/j.rmed.2018.02.010. Epub 2018 Feb 16.

PMID:
29605212
9.

House Dust Endotoxin Association with Chronic Bronchitis and Emphysema.

Mendy A, Salo PM, Cohn RD, Wilkerson J, Zeldin DC, Thorne PS.

Environ Health Perspect. 2018 Mar 23;126(3):037007. doi: 10.1289/EHP2452.

10.

The outcome and the influencing factors of the age of onset in post-mortem of chronic bronchitis patients: a retrospective study.

Zhu L, Ni Z, Luo X, Zhang Z, Wang S, Meng Z, Gu X, Wang X.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 21;13:645-652. doi: 10.2147/COPD.S157084. eCollection 2018.

11.

Exposure to cooking oil fumes and chronic bronchitis in nonsmoking women aged 40 years and over: a health-care based study.

Chen HC, Wu CF, Chong IW, Wu MT.

BMC Public Health. 2018 Feb 13;18(1):246. doi: 10.1186/s12889-018-5146-x.

12.

Ambient Air Pollution and Chronic Bronchitis in a Cohort of U.S. Women.

Hooper LG, Young MT, Keller JP, Szpiro AA, O'Brien KM, Sandler DP, Vedal S, Kaufman JD, London SJ.

Environ Health Perspect. 2018 Feb 6;126(2):027005. doi: 10.1289/EHP2199.

13.

Cigarette smoking and smoking-attributable diseases among Estonian physicians: a cross-sectional study.

Raag M, Pärna K.

BMC Public Health. 2018 Jan 30;18(1):194. doi: 10.1186/s12889-018-5105-6.

14.

Clinical Outcome of Eosinophilic Airway Inflammation in Chronic Airway Diseases Including Nonasthmatic Eosinophilic Bronchitis.

Cho J, Choi SM, Lee J, Park YS, Lee SM, Yoo CG, Kim YW, Han SK, Lee CH.

Sci Rep. 2018 Jan 9;8(1):146. doi: 10.1038/s41598-017-18265-2.

15.

Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.

Cazzola M, Calzetta L, Page C, Rogliani P, Matera MG.

Pulm Pharmacol Ther. 2018 Feb;48:185-194. doi: 10.1016/j.pupt.2017.11.009. Epub 2017 Dec 9. Review.

PMID:
29233650
16.

Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study.

Mejza F, Gnatiuc L, Buist AS, Vollmer WM, Lamprecht B, Obaseki DO, Nastalek P, Nizankowska-Mogilnicka E, Burney PGJ; BOLD collaborators; BOLD study collaborators.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700621. doi: 10.1183/13993003.00621-2017. Print 2017 Nov.

17.

Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry.

Jetmalani K, Thamrin C, Farah CS, Bertolin A, Chapman DG, Berend N, Salome CM, King GG.

Respirology. 2018 May;23(5):512-518. doi: 10.1111/resp.13215. Epub 2017 Nov 15.

PMID:
29141272
18.

Extending the Case-Control Design to Longitudinal Data: Stratified Sampling Based on Repeated Binary Outcomes.

Schildcrout JS, Schisterman EF, Mercaldo ND, Rathouz PJ, Heagerty PJ.

Epidemiology. 2018 Jan;29(1):67-75. doi: 10.1097/EDE.0000000000000764.

19.

Airway Mucin Concentration as a Marker of Chronic Bronchitis.

Kesimer M, Ford AA, Ceppe A, Radicioni G, Cao R, Davis CW, Doerschuk CM, Alexis NE, Anderson WH, Henderson AG, Barr RG, Bleecker ER, Christenson SA, Cooper CB, Han MK, Hansel NN, Hastie AT, Hoffman EA, Kanner RE, Martinez F, Paine R 3rd, Woodruff PG, O'Neal WK, Boucher RC.

N Engl J Med. 2017 Sep 7;377(10):911-922. doi: 10.1056/NEJMoa1701632.

20.

Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.

Calle Rubio M, Casamor R, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Aug 9;12:2373-2383. doi: 10.2147/COPD.S137872. eCollection 2017.

Supplemental Content

Loading ...
Support Center